Results 41 to 50 of about 5,414 (201)

Generalized morphea - a case report

open access: yes, 2018
Generalized morphea is a subtype of morphea in which widespread sclerotic plaques are seen without systemic involvement.
Aneela Asghar   +2 more
core   +1 more source

A case of eosinophilic fasciitis and generalized morphea overlap [PDF]

open access: yes, 2020
A 60-year old man developed skin hardening and edema on his extremities. Although he had been treated with oral prednisolone at another hospital, skin stiffness relapsed during tapering of prednisolone.
Yamamoto, Toshiyuki   +6 more
core   +1 more source

2547 Long-term response to treatment and disease recurrence in a prospective cohort of morphea patients

open access: yesJournal of Clinical and Translational Science, 2018
OBJECTIVES/SPECIFIC AIMS: Morphea (localized scleroderma) is an autoimmune disease characterized that is widely thought to have a monophasic course, in which an initial period of inflammation (activity) ultimately results in scarring, atrophy, and ...
Stephanie Florez-Pollack   +2 more
doaj   +1 more source

Treatment of morphea

open access: yesPifu-xingbing zhenliaoxue zazhi, 2022
Morphea is a fibrotic disease that primarily affects the skin and adjacent tissues, with uncertain pathogenesis. At present, there is no etiology-specific treatment available. In recent years, progress has been made in the treatment of morphea, including
Junjie CEN   +6 more
doaj   +1 more source

Generalized morphea

open access: yesDermatology Online Journal, 2003
A 69-year-old man presented with symmetric erythematous, hyperpigmented, and ivory-colored plaques on the trunk and extremities. His clinical history, laboratory analysis, and histopathologic examination were consistent with generalized morphea, a subtype of localized scleroderma.
openaire   +4 more sources

Genomics and epigenomics of tissue repair: Implications for personalized medicine

open access: yesPrecision Medical Sciences, EarlyView.
Genomic and epigenomic mechanisms govern tissue repair and regeneration through dynamic regulation of inflammation, cell fate, and extracellular matrix remodeling. The integration of multi‐omics, artificial intelligence, and precision regenerative therapies enables biomarker‐driven, personalized approaches to enhance healing and minimize fibrosis ...
Jharna Medhi   +7 more
wiley   +1 more source

Is adiponectin involved in morphea pathogenesis? – first observational study

open access: yesFrontiers in Immunology
BackgroundMorphea is a chronic inflammatory condition characterized by fibrosis of the skin and/or subcutaneous tissues. Adiponectin is an adipokine known for its anti-inflammatory and antifibrotic properties.
Adriana Polańska   +5 more
doaj   +1 more source

Cutaneous lymphomas – an update

open access: yesHistopathology, EarlyView.
Primary cutaneous lymphomas and lymphoproliferative disorders are defined by integrated clinical, histopathological, immunophenotypic and genetic features as diagnostic criteria also in the 5th edition of the WHO classification of haematolymphoid tumors.
Werner Kempf, Christina Mitteldorf
wiley   +1 more source

Plaque psoriasis and morphea in a patient on ustekinumab: A case report

open access: yesSAGE Open Medical Case Reports, 2023
A large number of autoimmune and fibrosing conditions associated with psoriasis and morphea have been reported in the literature. Currently, the relationship between psoriasis and morphea is unknown, and the coexistence of these conditions is quite rare.
Katrina Cirone, Ronald Vender
doaj   +1 more source

Controversy around the morphea

open access: yesAdvances in Dermatology and Allergology, 2021
Morphea, also known as localized scleroderma, is a chronic, autoimmune disease of connective tissue. It is characterized by a typical clinical feature. In morphea, there is no Raynaud's phenomenon, no sclerodactyly or no ulcerations on the fingertips.
Dańczak-Pazdrowska, Aleksandra   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy